These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 9469424

  • 21. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.
    de Palazzo IG, Gercel-Taylor C, Kitson J, Weiner LM.
    Cancer Res; 1990 Nov 15; 50(22):7123-8. PubMed ID: 2146012
    [Abstract] [Full Text] [Related]

  • 22. Structure and function of human IgA Fc receptors (Fc alpha R).
    Morton HC, van Egmond M, van de Winkel JG.
    Crit Rev Immunol; 1996 Nov 15; 16(4):423-40. PubMed ID: 8954257
    [Abstract] [Full Text] [Related]

  • 23. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G, Samarut C, Revillard JP.
    Ann Immunol (Paris); 1981 Nov 15; 132D(1):3-14. PubMed ID: 7347555
    [Abstract] [Full Text] [Related]

  • 24. Induction of porcine granulocyte-mediated tumor cytotoxicity by two distinct monoclonal antibodies against lytic trigger molecules (PNK-E/G7).
    Wierda WG, Johnson BD, Dato ME, Kim YB.
    J Immunol; 1993 Dec 15; 151(12):7117-27. PubMed ID: 8258715
    [Abstract] [Full Text] [Related]

  • 25. Characterization of the cytolytic trigger molecules G7/PNK-E as a molecular complex on the surface of porcine phagocytes.
    Aller SC, Cho D, Kim YB.
    Cell Immunol; 1995 Apr 01; 161(2):270-8. PubMed ID: 7697738
    [Abstract] [Full Text] [Related]

  • 26. Colostral neutrophils express Fc alpha receptors (CD89) lacking gamma chain association and mediate noninflammatory properties of secretory IgA.
    Honorio-França AC, Launay P, Carneiro-Sampaio MM, Monteiro RC.
    J Leukoc Biol; 2001 Feb 01; 69(2):289-96. PubMed ID: 11272280
    [Abstract] [Full Text] [Related]

  • 27. Crosslinking of the human Fc receptor for IgA (FcalphaRI/CD89) triggers FcR gamma-chain-dependent shedding of soluble CD89.
    van Zandbergen G, Westerhuis R, Mohamad NK, van De Winkel JG, Daha MR, van Kooten C.
    J Immunol; 1999 Dec 01; 163(11):5806-12. PubMed ID: 10570263
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89).
    van Egmond M, van Spriel AB, Vermeulen H, Huls G, van Garderen E, van de Winkel JG.
    Cancer Res; 2001 May 15; 61(10):4055-60. PubMed ID: 11358825
    [Abstract] [Full Text] [Related]

  • 29. Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.
    Elsässer D, Stadick H, Stark S, Van de Winkel JG, Gramatzki M, Schrott KM, Valerius T, Schafhauser W.
    Anticancer Res; 1999 May 15; 19(2C):1525-8. PubMed ID: 10365137
    [Abstract] [Full Text] [Related]

  • 30. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
    Valerius T, Stockmeyer B, van Spriel AB, Graziano RF, van den Herik-Oudijk IE, Repp R, Deo YM, Lund J, Kalden JR, Gramatzki M, van de Winkel JG.
    Blood; 1997 Dec 01; 90(11):4485-92. PubMed ID: 9373259
    [Abstract] [Full Text] [Related]

  • 31. Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients.
    Grossetête B, Viard JP, Lehuen A, Bach JF, Monteiro RC.
    AIDS; 1995 Mar 01; 9(3):229-34. PubMed ID: 7755910
    [Abstract] [Full Text] [Related]

  • 32. Identification of a human granulocyte functional antigen (GFA-2) involved in antibody-dependent cell-mediated cytotoxicity and phagocytosis.
    López AF, Begley G, Andrews P, Butterworth AE, Vadas MA.
    J Immunol; 1985 Jun 01; 134(6):3969-77. PubMed ID: 3989303
    [Abstract] [Full Text] [Related]

  • 33. Effective in vitro clearance of Porphyromonas gingivalis by Fc alpha receptor I (CD89) on gingival crevicular neutrophils.
    Kobayashi T, Yamamoto K, Sugita N, van Spriel AB, Kaneko S, van de Winkel JG, Yoshie H.
    Infect Immun; 2001 May 01; 69(5):2935-42. PubMed ID: 11292709
    [Abstract] [Full Text] [Related]

  • 34. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ, Luheshi NM, Beyaz N, Davies GC, Legg JW, Wu H, Dall'Acqua WF, Tsui P.
    MAbs; 2015 May 01; 7(4):743-51. PubMed ID: 25970007
    [Abstract] [Full Text] [Related]

  • 35. Tumor therapy with bispecific antibody: the targeting and triggering steps can be separated employing a CD2-based strategy.
    Wild MK, Strittmatter W, Matzku S, Schraven B, Meuer SC.
    J Immunol; 1999 Aug 15; 163(4):2064-72. PubMed ID: 10438945
    [Abstract] [Full Text] [Related]

  • 36. Effective targeting of pathogens to neutrophils via chimeric surfactant protein D/anti-CD89 protein.
    Tacken PJ, Hartshorn KL, White MR, van Kooten C, van de Winkel JG, Reid KB, Batenburg JJ.
    J Immunol; 2004 Apr 15; 172(8):4934-40. PubMed ID: 15067073
    [Abstract] [Full Text] [Related]

  • 37. Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction.
    Trezzini C, Jungi TW, Spycher MO, Maly FE, Rao P.
    Immunology; 1990 Sep 15; 71(1):29-37. PubMed ID: 1698715
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.